In line with increasing numbers of transgender (trans) and gender nonbinary people
requesting hormone treatment, the body of available research is expanding. More clinical …

Background: Transgender healthcare is a rapidly evolving interdisciplinary field. In the last
decade, there has been an unprecedented increase in the number and visibility of …

Importance Transgender and gender-diverse individuals face unique challenges, including
barriers to health care access and inequities in treatment, that may influence cancer risk and …

Background Increased mortality in transgender people has been described in earlier
studies. Whether this increased mortality is still present over the past decades is unknown …

A well-developed body of literature demonstrates that lesbian, gay, bisexual, transgender,
and queer (LGBTQ) individuals experience poorer health outcomes and report worse health …

Antiandrogens are frequently used with estradiol in transgender women seeking
feminization. Antiandrogens act by various mechanisms to decrease the production or …

Objectives: The primary aim of these guidelines is to evaluate the role of pharmacological
agents in the treatment and management of patients with paraphilic disorders, with a focus …

Transgender women are assigned male at birth but identified as women. The incidence of
gender dysphoria is estimated to be around 1% of the population. Gender dysphoria may be …

Abstract Purpose Gender Incongruence (GI) is a marked and persistent incongruence
between an individual's experienced and the assigned gender at birth. In the recent years …

Context Cyproterone acetate (CPA) is a competitive inhibitor of the androgen receptor and
exerts negative hypothalamic feedback. It is often used in combination with estrogens in …